Document is current
Any future updates will be listed below
-
Authors
Trotti, Lynn Marie https://orcid.org/0000-0003-2329-6847
Blake, Tyler
Hoque, Romy
Rye, David B.
Sharma, Surina
Bliwise, Donald L.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03772314 at ClinicalTrials.govDocuments that mention this clinical trial
Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial
https://doi.org/10.1007/s40263-024-01122-y
-
Funding
Funding for this research was provided by:
American Academy of Sleep Medicine Foundation (191-SR-18)
National Center for Advancing Translational Sciences (UL1TR002378)
National Institute of Neurological Disorders and Stroke (R01 NS111280)
- License Information
-
More Information
Article History
Accepted: 22 August 2024
First Online: 21 September 2024
Declarations
:
: This research project was made possible by an award from the American Academy of Sleep Medicine Foundation, a foundation of the American Academy of Sleep Medicine. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors, and do not necessarily reflect the views of the American Academy of Sleep Medicine Foundation. This work was additionally supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378 (statistical consultation) and the National Institutes of Neurological Disorders and Stroke (R01 NS111280 to LMT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: LM Trotti is a member of the Board of Directors of the American Academy of Sleep Medicine, the American Academy of Sleep Medicine Foundation, and the American Board of Sleep Medicine; funds for this work were awarded by the Foundation prior to Dr. Trotti’s joining of these boards. DB Rye reports consulting fees from Jazz and Takeda, who have or are developing treatments for idiopathic hypersomnia and/or narcolepsy type 2. The other authors have no conflicts to report relevant to this manuscript.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: This protocol (IRB00108167) was approved by Emory University’s Institutional Review Board and performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: All participants provided written informed consent.
: N/A.
: N/A.
: (1) Conception and design of the study (LMT, DBR, DLB); (2) acquisition or analysis of Data (all authors); (3) drafting the manuscript (LMT); (4) reviewing the manuscript for important intellectual content (all authors). All authors have read and approve the final version of the manuscript and agree to be accountable for the work.
